Nyxoah SA Stock Forum

$Nyxoah SA(NYXH.US)$ Nyxoah Says DREAM US Pivotal Study Meets Primary Endpoints
Moomoo 24/7· 11 mins ago
Olivier Taelman, Nyxoah's Chief Executive Officer, said, "We are finalizing the fourth and final module submission in the PMA application and I look forward to launching Genio in the U.S, pending FDA approval."

$Nyxoah SA(NYXH.US)$ Nyxoah Announces 2024 Strategic Priorities; Seeks To Complete Patient Follow Up In The DREAM U.S. Pivotal Study And Report Efficacy And Safety Data By Early April
Benzinga· 2 mins ago

Upgrades
• $Bank First(BFC.US)$ : Piper Sandler Upgrades to Overweight From Neutral - PT $84 (from $76)
• $E2open Parent(ETWO.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $12
• $Harmonic(HLIT.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $11
• $MarketAxess(MKTX.US)$ : Compass Point Upgrades to Neutral from Sell - PT $275 (from $300)
• $PBF Energy(PBF.US)$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $30 (from $20)
• $Range Resources(RRC.US)$ : Piper S...

Upgrades
• $Banc of California(BANC.US)$: Raymond James Upgrades to Outperform from Market Perform - PT $22
• $Cullen/Frost Bankers(CFR.US)$: Raymond James Upgrades to Outperform from Market Perform
• $W.W. Grainger(GWW.US)$: Wolfe Research Upgrades to Outperform from Peerperform
• $Invitation Homes Inc(INVH.US)$: Evercore ISI Upgrades to Outperform from In Line - PT $46 (from $44)
• $PCB Bancorp(PCB.US)$: Raymond James Upgrades to Outperform from Market Perfor...